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Background: Complex malaria infections are defined as those containing more than one genetically distinct
lineage of Plasmodium parasite. Complexity of infection (COI) is a useful parameter to estimate from patient
blood samples because it is associated with clinical outcome, epidemiology and disease transmission rate.
This manuscript describes a method for estimating COI using likelihood, called COIL, from a panel of bi-allelic
genotyping assays.
Methods: COIL assumes that distinct parasite lineages in complex infections are unrelated and that genotyped
loci do not exhibit significant linkage disequilibrium. Using the population minor allele frequency (MAF) of the
genotyped loci, COIL uses the binomial distribution to estimate the likelihood of a COI level given the prevalence
of observed monomorphic or polymorphic genotypes within each sample.
Results: COIL reliably estimates COI up to a level of three or five with at least 24 or 96 unlinked genotyped loci,
respectively, as determined by in silico simulation and empirical validation. Evaluation of COI levels greater than
five in patient samples may require a very large collection of genotype data, making sequencing a more
cost-effective approach for evaluating COI under conditions when disease transmission is extremely high.
Performance of the method is positively correlated with the MAF of the genotyped loci. COI estimates from
existing SNP genotype datasets create a more detailed portrait of disease than analyses based simply on the
number of polymorphic genotypes observed within samples.
Conclusions: The capacity to reliably estimate COI from a genome-wide panel of SNP genotypes provides a
potentially more accurate alternative to methods relying on PCR amplification of a small number of loci for
estimating COI. This approach will also increase the number of applications of SNP genotype data, providing
additional motivation to employ SNP barcodes for studies of disease epidemiology or control measure efficacy. The
COIL program is available for download from GitHub, and users may also upload their SNP genotype data to a web
interface for simple and efficient determination of sample COI.
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Complexity of infection (COI) in the context of malaria
may be defined as the number of genetically distinct
Plasmodium parasite types simultaneously infecting a
patient. Complex (COI >1) infections may be generated
by multiple bites from parasite-infected mosquitoes or
by a single bite from a mosquito infected with multiple
genetic parasite types. COI is an important parameter to
measure for two reasons: 1) its potential bearing on clin-
ical disease outcome and, 2) the information it can pro-
vide about disease transmission.
The relevance of COI to disease manifestation and im-
mune response is well established, but mechanisms are
not yet understood and correlations are sometimes
contradictory. Investigators have found an inverse asso-
ciation between COI and patient age in diverse geo-
graphic study sites [3-6], suggesting that acquired
immunity to specific parasite strains may cumulatively
impact COI. Immunization with the SPf66 [7] or RTS,S/
AS02A [8] vaccines has been found to reduce both COI
and disease morbidity, suggesting a possible causal link
between these two phenomena. While some studies have
documented a positive association between COI and
symptomatic malaria [9,10] others have found an inverse
association [11-13], suggesting that the clinical and epi-
demiological consequences of COI are important but not
yet fully understood. One recent study found a highly sig-
nificant positive association between COI and severe mal-
aria in Kampala, Uganda [14]. The true relationship
between COI and disease outcome may differ in Plasmo-
dium vivax from Plasmodium falciparum, and disease
outcome may further be complicated by simultaneous in-
fections of both species.
Knowing the distribution of COI across a patient
population can reveal much about the nature of disease
transmission and epidemiology. For P. falciparum infec-
tions, COI in Senegal has been found to be seasonal and
positively associated with the degree of parasitaemia in
individual patients [15]. In Sudan and Tanzania, COI has
been used as a metric to study the rate of disease trans-
mission [16,17]. Nkhoma and colleagues recently ob-
served that polymorphic SNP genotypes (expected if
COI >1) declined in prevalence over the course of a dec-
ade along the Thai-Burma border, in tandem with a de-
cline in disease transmission in that region [18].
Given the usefulness of COI, a variety of methods have
been developed for estimation of this statistic from clin-
ical samples. The most common method to evaluate
COI involves PCR amplification of one or more genetic
loci (msp1, msp3, glurp) known to be segregating numer-
ous insertion/deletion (indel) polymorphisms, and then
estimating COI as the maximum number of amplicon-
length alleles observed at the most diverse locus for a
given sample [19]. This method requires subjectiveinterpretation of agarose gels, has been observed to yield
inconsistent PCR results, and may be insensitive due to
the relatively small number of indel polymorphisms sur-
veyed [20]. Other methods of evaluating COI have
focused on reconstructing haplotypes from sequencing
or genotyping data at one or a few loci [21]. These
haplotype-reconstruction approaches are computationally
intensive, making their application to more than five loci
hard to implement, with consequent limited sensitivity for
reliable COI estimation in highly complex infections. The
FWS metric of Auburn and colleagues [22] captures
within-host heterozygosity relative to population diversity
from sequence-based SNP data, but does not provide a
direct estimate of COI. The estMOI software developed
recently by Assefa and colleagues [23] utilizes phasing in-
formation of alleles in SNP-dense regions of the genome
to estimate COI, but requires deep whole genome shotgun
sequence data, which is costly to generate at large scale.
With the advent of sequence-based genome-wide poly-
morphism catalogues for many parasite populations, it is
becoming feasible to design panels of SNP-based geno-
typing assays for assessing parasite genetic diversity
and geographic origin in collections of clinical samples
[18,24-28]. Because Plasmodium parasites are haploid
during the stages of their life history during which they
infect humans, the presence of polymorphic genotype
calls in a SNP-based genotyping assay panel, or molecu-
lar barcode, is a clear indication that COI is greater than
one for a particular sample. However, no formal method
exists to directly estimate COI from genotyping data in
a haploid organism such as Plasmodium spp.
Given the potential importance of COI and the poten-
tial inaccuracy or computational complexity of existing
methods for estimating COI, there was a perceived need
for new tools. This manuscript describes a computation-
ally efficient, likelihood-based method that produces an
estimation of COI from SNP genotyping data, using bi-
nomial probability calculations of monomorphic vs poly-
morphic genotype likelihoods produced using the
population minor allele frequency (MAF) of the SNPs
comprising the barcode panel. Via in silico simulation
and empirical validation, it is shown that SNP barcodes
containing at least 24 unlinked assays can reliably re-
solve COI up to a level of three, and that panels of at
least 96 unlinked assays can resolve COI up to a level of
five, which is sufficient for a majority of transmission
conditions. Though this manuscript focuses on applica-
tions to Plasmodium spp., this method is suitable for ap-
plication to any haploid organism with polymorphism
genotype data meeting the assumptions described below.
Methods
COIL employs a Bayesian approach to assign probabil-
ities to distinct COI levels (C) given the data in a
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probability distribution for COI and the ability to com-
pute the likelihood of COI given a barcode, which is
equivalent to computing the probability of observing the
barcode at a given COI:
P C∣Gð ÞαL C∣Gð ÞP Cð Þ ¼ P G∣Cð ÞP Cð Þ
Two assumptions are made to simplify the computa-
tion of the COI likelihood. The first is that the individual
assays in the barcode (Gi) are independent, and do not
exhibit significant linkage disequilibrium (LD) with other
assays. In most P. falciparum and P. vivax populations,
LD is found over physical distances of 10 kb or less
[29,30], suggesting a minimum spacing for SNP assays
used in this application. When this assumption of assay
independence is met, it means that the probability of ob-
serving the composite barcode genotype for a sample
with a particular COI is equivalent to the product of the
probability of observing the results of each of the com-
ponent assays:
P G∣Cð Þ ¼
Y
i
P Gi∣Cð Þ
The second simplifying assumption is that the individ-
ual parasite lineages comprising a complex infection are
independent and randomly selected from the larger
parasite population. In a complex infection assayed for
biallelic polymorphisms, the contribution of each strain
to the final genotype for each particular assay is there-
fore equivalent to a series of independent Bernoulli tri-
als, and the overall tally of the number of alternate
(non-wild-type/non-reference) alleles conditional upon a
given COI follows a binomial distribution. If one denotes
Xi as the count of alternate alleles at site i with minor al-
lele frequency, then
Xi∣C∼Binomial C; pið Þ
Biallelic genotyping assays yield three possible results
(not including assay failure) for a haploid pathogen like
Plasmodium, enumerated as:
0. No alternate alleles (monomorphic reference)
1. Only alternate alleles (monomorphic alternate)
2. Mixture of reference and alternate alleles
(polymorphic)
The probabilities of observing these outcomes can be
computed using the binomial distribution:PðGi ¼ 0 Cj Þ ¼ PðXi ¼ 0 Cj Þ ¼ 1−pið Þc
PðGi ¼ 1 Cj Þ ¼ PðXi ¼ C Cj Þ ¼ pci
PðGi ¼ 2 Cj Þ ¼ 1−PðGi≠2 Cj Þ
¼ 1−P Gi ¼ 0 Cj Þ−P Gi ¼ 1 Cj Þðð
Assay failures are ignored and do not contribute to the
likelihood calculation. The minor allele frequencies for
each assay can be supplied if they are already known for
a given population. Alternatively, they can be estimated
from singleton infections (which are assumed to be
those containing no polymorphic calls) in a given sam-
ple. For the methods here, a Bayesian approach to assay
MAF is used, where the allele counts are expected to fol-
low a binomial distribution and a Beta(1,1) prior distri-
bution is applied to the MAFs (which is equivalent to
the Uniform(0,1) prior). The effect of doing this is to
pad the counts of the alleles by 1, which is useful when
the minor allele frequency is small and the minor allele
is not observed in singleton infections.
This approach was further refined by building in a tol-
erance for inevitable genotyping errors. A genotyping
error is defined as a scenario in which the observed out-
come of an assay (Gi
*) does not match the true state of
the polymorphism in the sample. The error rates (E) can
be described as a stochastic matrix as follows:
Egh ¼ P Gi ¼ h∣Gi ¼ g
 
Using this matrix, one can calculate the probability of
observing any outcome of the assay as:
P Gi ¼ h∣C
  ¼X2
g¼oP G

i ¼ h∣Gi ¼ g
 
P Gi ¼ g∣Cð Þ
To find the posterior COI distribution, the likelihood
for each COI level is multiplied by the prior probability
for that COI, and then the likelihoods are normalized to
sum to one. The choice of prior can be informative if
there is some information about the prevalence of com-
plex infections. Alternatively, the COI prior can simply
be defined as a discrete uniform distribution with the
maximum value being the limit of detection for the
given barcode. The default prior on the web implemen-
tation of COIL assumes no external information exists
about the prevalence of complex infections, and utilizes
a uniform distribution with a maximum COI level of
five. The downloadable version of COIL allows users to
manipulate the prior.
Results
The fundamental utility of this algorithm derives from
the property that, for a given minor allele frequency and
genotyping error rate, the number of polymorphic calls
in a composite genotype is expected to follow a binomial
distribution, the moments of which are dependent on
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the degree to which the underlying probability mass dis-
tributions of the expected number of polymorphic calls
vary depending on MAF, for barcodes based on 24 vs 96
assays. Increasing the MAF from 0.2 to 0.4, or the num-
ber of assays from 24 to 96, greatly increases the separ-
ation of the probability mass distributions for samples of
different COI levels, especially when COI is less than
five. Mass distributions for samples with COI = 1 depart
from the y-axis (zero polymorphic calls) due to the
built-in tolerance for genotyping errors. The power of
this algorithm is contingent on the separation of these
probability mass distributions within the relevant COI
range.
The potential performance of this approach was first
evaluated using in silico simulations. Simulated geno-
types were generated for samples with a true COI ran-
ging from one to five, under conditions in which the
assayed SNPs all had minor allele frequencies of 0.2 or
0.4, and in which the size of the assay set was either 24
or 96. After generating 100 simulated genotypes for each
condition under a range of COI levels, the genotypes
were run through the COIL algorithm and checked for
concordance between the true COI and the maximum a
posteriori COI predicted by COIL. Figure 2 illustrates
the outcome of this in silico experiment. Accuracy is
relatively low with 24 assays and an assay MAF of 0.2
(Figure 2a), but improves markedly up to a level of COI = 3Figure 1 In silico analysis of resolution. Analyses of probability mass dis
MAF = 0.2, c) 24 SNPs with MAF = 0.4, and d) 96 SNPs with MAF = 0.4. Sepa
the COIL algorithm.(84.4% correct calls) when assay number is kept the same
and MAF is increased to 0.4 (Figure 2b). For a barcode
of 96 assays, performance is improved at MAF = 0.2
(Figure 2c) relative to the set of 24 assays, but remains defi-
cient for COI >3. For a barcode containing 96 SNPs with
MAF = 0.4 (Figure 2d), accuracy is high up to a COI level
of five (91.4% correct calls). These results indicate that
while increasing assay number can compensate somewhat
for low assay MAF, high assay MAF is a very important
parameter for reliable COI estimation at complexity levels
greater than two.
Next, the performance of the COIL algorithm was
evaluated on a collection of empirical genotype data
from 21 clinical DNA samples obtained from patients
infected with P. vivax in French Guiana. Plasmodium
vivax infections have been increasing in prevalence in
this region over the past ten years. Plasmodium vivax is
distinct from P. falciparum in its capacity to remain la-
tent in the liver and induce relapse infections weeks or
months later, leading to the expectation that polyge-
nomic infections could be more common even in rela-
tively low transmission settings. Each sample was
genotyped at 36 SNPs using an Illumina Eco platform,
as described elsewhere [31]. Each sample was also previ-
ously genotyped for length polymorphisms at 15 micro-
satellite loci (Additional file 1), and COIL was run using
previously determined MAF estimates for each assayed
SNP (Additional file 2). Because microsatellite locitributions for COI 1-6 using a) 24 SNPs with MAF = 0.2, b) 96 SNPs with
ration of distributions is positively associated with resolution power of
Figure 2 Validation with simulated genotype data. Plots represent algorithm performance for in silico simulated samples exhibiting "true"
COI levels between 1 and 5 (100 samples per COI level), with varying grades of genotyping data: a) 24 SNPs with MAF = 0.2, b) 96 SNPs with
MAF = 0.2, c) 24 SNPs with MAF = 0.4, and d) 96 SNPs with MAF = 0.4. Accuracy improves with more SNPs and higher MAF.
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sample COI was evaluated as the maximum number of
alleles observed at any single locus within the microsat-
ellite panel. The microsatellite-based COI estimates and
the SNP-based COI estimates produced with COIL were
found to exhibit general concordance (Table 1).
In 15 of 23 samples there was perfect agreement between
the maximum a posteriori COIL estimate of COI and the
maximum number of alleles observed at any microsatellite
locus. In one case (sample L285) the maximum a posteriori
COIL estimate was incorrect, but the 95% credibility inter-
val captured the microsatellite-based COI estimate. The
remaining seven cases of disagreement in COI estimates fall
into three categories. In some cases COIL may underesti-
mate COI as a result of over-tolerance for occasional SNP
genotyping errors that render polymorphic calls from pre-
sumably monomorphic loci (e.g., sample N524, which ex-
hibits ten polymorphic calls but is called as COI = 2 by
COIL). In other cases, COIL may be correctly estimating
COI, but the microsatellite data may be incorrectly indicat-
ing a higher COI level on the basis of a single locus yielding
two or more alleles with similar lengths (Additional file 1;
e.g., samples N427, N492). Resolution of two microsatellite
alleles with a length difference of 10 bp or less could be
subject to interpretation error, and the biallelic microsatel-
lite results for samples N427 and N492 have not been con-
firmed by subcloning and sequencing or an alternate
methodology. Finally, some cases of disagreement appear
difficult to explain on the basis of simple genotyping error
or algorithmic bias, and may result from legitimate discord-
ance in the underlying biological signal between the SNPand microsatellite assays (e.g., samples J249, L110). For ex-
ample, some complex infections may contain highly related
parasite strains that exhibit a polymorphic signal only in
limited genomic regions that were differentially covered by
these small panels of SNP and microsatellite markers.
Following these validation experiments, COIL was ap-
plied to several additional collections of patient samples.
First, genotype data were acquired from a recently pub-
lished collection of Illumina Goldengate genotyping results
for 96 SNPs assayed in a longitudinal collection of 1,731
P. falciparum samples from northwest Thailand. The au-
thors of the original study observed a steady decline from
2001-2010 in the proportion of samples exhibiting poly-
morphic SNP calls (63 vs 14% in 2001 vs 2010), and noted
that this signal was among the strongest genomic correlates
of the decrease in disease incidence and transmission ob-
served in the region during that time interval. When these
data are translated into COI estimates the decline in disease
incidence manifests as a very consistent change in the dis-
tribution of COI in the patient population (Figure 3). Ap-
proximately half of the patient samples in 2001 exhibited
COI >1, and over 5% exhibited COI >2. By 2010, over 90%
of patient samples exhibited COI = 1, and virtually all com-
plex infections were COI = 2.
A comparable observation of longitudinal variation in
the COI distribution over time can be made from SNP
barcode data (Additional file 3) from P. falciparum sam-
ples collected in Senegal, using 24 SNPs genotyped with
a high resolution melting (HRM) platform on 974 clin-
ical samples collected between 2006 and 2012 [26], with
MAF estimates derived from presumed singleton
Table 1 Concordance of SNP and microsatelitte-based COI estimates in 21 clinical Plasmodium vivax samples
Sample SNP barcode No.
poly
SNPs
SNP estimated
COI [95% CI]
Max. posterior
probability
MS estimated
COI
No. poly
MS
SNP/MS
agree?
L066 CGTCGTACAGACCCATCCATCCGCTGCACCACGTAA 0 1 [1,1] 1 1 0 Yes
L099 CGCTNCACNAACCTATCCAGNCANTGNNNCNAGTAC 8 2 [2,2] 0.9994 2 2 Yes
N121 CGTCGCGCGGACCTGTCCGTCCGCTACGCTGAACGC 0 1 [1,1] 1 1 0 Yes
N188 CGCCGTACGGACTTGTCCGTTCGTTGCGCTGAATAC 0 1 [1,1] 1 1 0 Yes
N257 NGNNNNANNNNCTCANNNNGNNNCNNNGCCAAGNNC 21 3 [3,5] 0.5813 3 7 Yes
N315 CGNNNNGTAAACNCATCCNGNCGCTACGCNNAGNAN 11 2 [2,2] 0.9881 2 2 Yes
N426 CGNTNNATNNNCNCATNNNNCTNNNNCGNNNAGCAN 19 3 [2,4] 0.6174 3 6 Yes
N464 CGTCGCACGGACTCACCTGTTCGCTGCGCCGAGCAC 0 1 [1,1] 1 1 0 Yes
N471 CTCCGTACGGACTTGTCCGTCCGCTGCGCCAAGTAC 0 1 [1,1] 1 1 0 Yes
M396 CNCCGTNCGGACCCANNCANCCNCTNCGCCNNGNNN 12 2 [2,2] 0.972 2 1 Yes
J073 CGCTGCATNNACCTGNCNNGTCNCNNCGCCAAGTAC 8 2 [2,2] 0.9989 2 3 Yes
J116 CGTCATGTAGGCCTACCTGGCCGCTGCGTCACGTAC 0 1 [1,1] 1 1 0 Yes
J244 CGTTATATGGACCTACCCAGCTGCCGCGCCAAATAC 0 1 [1,1] 1 1 0 Yes
J255 CGCCGTGCGGACTTGCCCGTTCATTGCGCCAAGTAC 0 1 [1,1] 1 1 0 Yes
J268 CGCTATACAAACCCATCCGTTCACTGTGCCACGCAC 0 1 [1,1] 1 1 0 Yes
L285 CGCCGTGCNGACTNGTCCGTCCGCTGCNCCAAGCNC 4 1 [1,2] 0.7197 2 3 Partial
J096 NGCNGNACGGACTTGCCCGTCCGTTGCGCTGAATAC 3 1 [1,1] 0.9988 2 2 No
L110 CNCCGTACNNANTTNNCCGTCNGTTGNGCTGAATAC 8 2 [2,2] 0.999 1 0 No
N427 CGCTATACGAACTTACCTATCTGCTGCGCCAAGCGC 0 1 [1,1] 1 2 1 No
N492 CGTCGCACAAGCTCGTCCGGTCGTTGCGCTGAGTAC 0 1 [1,1] 1 2 1 No
N524 CGNCGTNTNAACCCNCCNGGCTNCCANNCTAAGNNC 10 2 [2,2] 0.9989 3 5 No
M496 CGCTGCATAAACCCATCTAGTTACTGCGCCACGTAC 0 1 [1,1] 1 2 1 No
J249 CTCCGCACAAACTCGTCCGTCTACTACGCCGAGCAC 0 1 [1,1] 1 2 2 No
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hibits less of a consistent temporal trend (Figure 4), pos-
sibly owing to lower baseline level of disease
transmission. However, a clear decrease in the propor-
tion of single infections is observable in 2007 and 2012
relative to other years, perhaps indicative of temporarily
increased transmission rates during those intervals.
Discussion
Two assumptions of independence were made in the
creation of the COIL algorithm: 1) independence of ge-
notypes among barcode assays, and 2) independence of
parasite lineages within complex infections. To evaluate
the usefulness of COIL in situations where one or both
of these assumptions may be violated, the consequences
of departures from these assumptions were evaluated.
The binomial distribution is the basis of COIL, and is
key to understanding the consequences of departures
from the assumptions. The binomial distribution is the
result of n independent Bernoulli trials, each of which
return a binary outcome. This is applied in two ways to
the data: first, whether a genotype call at a particularassay is polymorphic, and secondly, in the distribution of
alleles at a binary assay. If n independent Bernoulli trials
are performed each with the probability of success p, the
expected value of the resulting binomial distribution is
np and the variance is np(1-p).
Because Bernoulli trials are by definition independent,
correlation between the trials naturally results in a differ-
ent distribution. The expected value is the same, but the
variance changes. If X is a random variable that is the sum
of n Bernoulli random variables Xi each with probability
of success p, where the ith and jth variables have correl-
ation ρij, then the variance of X increases with ρij:
E Xð Þ ¼ E
X
i
Xi
 !
¼
X
i
E Xið Þ ¼
X
i
p ¼ np
Var Xð Þ ¼ Var
X
i
Xi
 !
¼
X
i;j
cov Xi;Xj
 
¼
X
i;j
ρijp 1−pð Þ ¼ nþ 2
X
i<j
ρij
" #
p 1−pð Þ
This equation illustrates that increased genotypic cor-
relation will cause an increased variance, resulting in
Figure 3 Application to longitudinal genotype data (96 SNPs) from Thailand. In concert with an observed decline in malaria transmission
between 2001 and 2010 in Southeast Asia, COIL results indicate a steady shift in the COI distribution of malaria infections in a collection of 1,731
clinical samples. Data were previously published and obtained from [18].
Galinsky et al. Malaria Journal 2015, 14:4 Page 7 of 9
http://www.malariajournal.com/content/14/1/4more extreme values in the correlated binomial distribu-
tion. This notion will be revisited below.
The first assumption is that the assays within a par-
ticular barcode are independent. This may not be true if
a particular sample exhibits high levels of LD. The ef-
fects of this can be minimized by genotyping loci that
are physically distant in the genome (at least 10-100 kb
for most parasite populations [29]) or that reside onFigure 4 Application to longitudinal genotype data (24 SNPs) from Se
for all years except 2007 and 2012, which exhibit infections with COI rangin
some of which were analysed previously [26].different chromosomes. In a highly inbred population,
however, even polymorphic loci on different chromo-
somes may exhibit significant LD, making it impossible to
conform with the assumption of assay independence.
Violation of the independent-assay assumption will re-
sult in overdispersion of the binomial distribution, and as
a result COIL will render more extreme COI estimates
(see in silico simulations in Additional file 4). If onenegal. COIL reflects the dominance of single infections in this country
g up to five. Genotype data were collected from 974 clinical samples,
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morphic call, then the other member of the pair is likely
to be polymorphic as well. The converse is also true in the
case of monomorphic calls. Thus, an infection that has a
true COI of three will be more likely to yield a COI esti-
mate of two or four. The net result is that the COI
estimates for individual samples will be less accurate.
However, these antagonistic effects cancel each other in
large collections of samples, and therefore population esti-
mates of COI distribution are predicted to be unbiased by
violation of the assumption of assay independence. This
underscores the value of using large sample sets for
obtaining accurate COI estimates with COIL.
COIL’s second assumption is that the individual parasite
lineages comprising complex infections are randomly
chosen from the larger parasite population, exhibiting a
degree of genomic similarity to each other comparable to
that observable between any set of strains observed in sin-
gle infections. If this assumption is violated (for example if
strains within complex infections exhibit higher genomic
similarity to each other than randomly chosen strains
from single infections) COIL will naturally underestimate
the COI for such complex infections (Additional file 4).
Recent common ancestry will result in a higher incidence
of monomorphic genotypes, and there is no balancing ef-
fect as in the assay non-independence example.
Several studies suggest that complex infections may be
serially co-transmitted, resulting in increasing levels of gen-
omic homogenization via multiple generations of inbreed-
ing [9,32-34]. Over time, this process may yield complex
infections composed of parasite strains exhibiting ex-
tremely high genomic similarity to each other. COIL is un-
equipped to reliably estimate COI in such situations, which
may require single cell sequencing or genotyping ap-
proaches for precise disambiguation of highly similar gen-
omic lineages.
A meristic measurement such as COI may be inappro-
priate for describing complex infections composed of
highly similar parasite lineages, and that a continuous
metric could better capture the complexity of such situa-
tions. In addition to discrete maximum a posteriori esti-
mates, COIL provides a posterior distribution describing
the uncertainty of the COI prediction, which may prove
useful in detecting the presence of serially co-transmitted
complex infections. The incidence of such infections and
their relevance to predicting clinical outcome or under-
standing disease transmission dynamics remain to be
thoroughly described, in part due to the current cost and
technical complexity of single-cell genomic approaches.
This report demonstrates that the number of genetic-
ally unrelated parasite lineages in patient samples can be
estimated inexpensively from SNP genotyping data,
which can be derived from bulk genomic DNA extracted
from a wide variety of clinical sample formats. Theapplications of such data for understanding disease eti-
ology and epidemiology will multiply as the size and
number of such datasets grow and yield new insights
into parasite biology.
Conclusions
COI will be a useful parameter to estimate to judge the
efficacy of early-stage malaria elimination campaigns.
This manuscript demonstrates that SNP genotype data
have the potential to yield accurate estimates of COI, es-
pecially in cases where at least 96 SNPs are assayed and
most SNPs exhibit a high MAF in the studied popula-
tion. The COIL program is available for download from
GitHub [1], and users may also upload their SNP geno-
type data to a web interface [2] for simple and efficient
determination of sample COI.
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